Biological product sealing failure detection method based on image recognition
Through an image recognition-based method, combined with texture consistency analysis and convolutional neural network, the problem of poor seal failure detection of biological products is solved, and more efficient and accurate seal detection is achieved.
Patent Information
- Application Number
- CN202411462732.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-19
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-10-19
AI Technical Summary
In the prior art, the accuracy of seal failure detection of biological products is poor, and it is difficult to accurately distinguish between real defects and normal structural characteristics, resulting in inaccurate seal failure detection.
Using an image recognition method, the biological products are sealed through the first flexible sealing material and the second flexible sealing material, and the sealed area image information is collected on the detection platform, and the false defect area is extracted by a defect recognizer to achieve texture consistency. Analysis, combining region clustering and convolutional neural network recognizer, determine the true defect area and seal failure marking according to the failure size specification.
It improves the accuracy and efficiency of seal detection of biological products, can more accurately identify seal failures, and reduce misjudgment and omissions.
Smart Images

Figure CN118961756A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of seal detection, and in particular to a method for detecting seal failure of biological products based on image recognition. Background Art
[0002] During the production and storage of biological products, the integrity of the seal is critical to ensure the safety, effectiveness and stability of the product. Biological products, including but not limited to drugs, vaccines, biotechnology products, etc., usually need to be stored and transported in a sterile and sealed environment to prevent microbial contamination and product degradation. However, defects in sealing materials or mistakes in the sealing process may cause seal failure, thus affecting the quality and safety of the product. Traditional seal detection methods usually use defect recognition models for identification, which can identify defects in non-sealed joint areas. However, the sealing area is usually accompanied by complex wrinkles and textures. These characteristics make it difficult for general defect recognition models to accurately distinguish between real defects and normal structural features. For example, the natural wrinkles of the seal may be misjudged as defects, while real fine cracks or leaks may be missed due to the insensitivity of the model. Summary of the invention
[0003] The present application provides a method for detecting sealing failure of biological products based on image recognition, which solves the technical problem of poor accuracy of sealing failure detection of biological products in the prior art.
[0004] In view of the above problems, the present application provides a method for detecting sealing failure of biological products based on image recognition.
[0005] The present application provides a method for detecting sealing failure of biological products based on image recognition, the method comprising: The biological product is sealed by a first flexible sealing material and a second flexible sealing material and transmitted to a first detection platform, wherein the biological product has a sealing area positioning coordinate on the first detection platform, wherein the sealing area is a sealing boundary area between the first flexible sealing material and the second flexible sealing material; the camera is activated to collect the sealing area image information of the biological product based on the sealing area positioning coordinate; the sealing area image information is processed by a defect identifier to extract a false defect area; a texture consistency analysis is performed on the false defect area to obtain a selected defect area; when the size specification of the selected defect area meets the failure size specification, the biological product is marked as sealed as failed.
[0006] One or more technical solutions provided in this application have at least the following technical effects or advantages: First, the biological product is sealed by a first flexible sealing material and a second flexible sealing material and transmitted to a first detection platform. The biological product has a sealing area positioning coordinate on the first detection platform, wherein the sealing area is the sealing boundary area of the first flexible sealing material and the second flexible sealing material. Next, the camera is activated to collect the sealing area image information of the biological product based on the sealing area positioning coordinate. Then, the sealing area image information is processed by a defect identifier to extract the false defect area. Finally, a texture consistency analysis is performed on the false defect area to obtain a selected defect area; when the size specification of the selected defect area meets the failure size specification, the biological product is marked as sealed. The technical problem of poor accuracy in the detection of sealing failure of biological products in the prior art is solved, and the technical effect of improving detection efficiency and accuracy is achieved through image recognition technology. BRIEF DESCRIPTION OF THE DRAWINGS
[0007] In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the following briefly introduces the drawings required for use in the description of the embodiments. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.
[0008] Figure 1 A schematic diagram of a flow chart of a biological product sealing failure detection method based on image recognition provided in an embodiment of the present application; Figure 2 A schematic diagram of the process of performing texture consistency analysis in the method for detecting sealing failure of biological products based on image recognition provided in an embodiment of the present application. DETAILED DESCRIPTION
[0009] The present application solves the technical problem of poor accuracy in the prior art of biological product seal failure detection by providing a biological product seal failure detection method based on image recognition.
[0010] The following will be combined with the drawings in the embodiments of the present application to clearly and completely describe the technical solutions in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, rather than all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of this application.
[0011] It should be noted that the terms "including" and "having" are intended to cover non-exclusive inclusions. For example, a process, method, system, product or server that includes a series of steps or units is not necessarily limited to those steps or units explicitly listed, but may include other steps or modules that are not explicitly listed or are inherent to these processes, methods, products or devices.
[0012] Examples, such as Figure 1 As shown, the embodiment of the present application provides a method for detecting sealing failure of biological products based on image recognition, wherein the method comprises: The biological product is sealed by the first flexible sealing material and the second flexible sealing material and transmitted to the first detection platform, and the biological product has a sealing area positioning coordinate on the first detection platform, wherein the sealing area is the sealing interface area between the first flexible sealing material and the second flexible sealing material.
[0013] In the sealing test process of biological products, the biological products are first sealed with the first flexible sealing material and the second flexible sealing material. After the sealing is completed, the biological products are transferred to the dedicated first testing platform. On the first testing platform, each biological product is assigned a precise sealing area positioning coordinate, which indicates the sealing area position where the first flexible sealing material and the second flexible sealing material meet.
[0014] Furthermore, the biological product is sealed by the first flexible sealing material and the second flexible sealing material and transmitted to the first detection platform, and the biological product has a sealing area positioning coordinate on the first detection platform, including: Obtain sealing control parameters of the first flexible sealing material and the second flexible sealing material for the biological product, wherein the sealing control parameters have coordinate feature identifiers; perform regional clustering analysis on the coordinate feature identifiers based on the sealing control parameters to obtain regional clustering results, wherein the same categories of the regional clustering results have the same sealing control parameters; and add the regional clustering results into the sealing area positioning coordinates.
[0015] Specifically, the key control parameters when the first flexible sealing material and the second flexible sealing material are used to seal the biological product are obtained. The sealing control parameters not only reflect the physical and chemical conditions of the sealing process, but also have coordinate feature identifiers, that is, their correspondence with the sealing area in spatial position; the sealing control parameters with coordinate feature identifiers are used to perform regional clustering analysis so that data points with similar characteristics can be divided into the same category. Optionally, according to the similarity of the sealing control parameters, K-means clustering is used to cluster different coordinate feature identifiers to form regional clustering results. The regional clustering results of the same category will have the same sealing control parameters; the regional clustering results are integrated into the sealing area positioning coordinates. By combining the regional clustering results with the sealing area positioning coordinates, the sealing effect can be evaluated more accurately.
[0016] The camera is activated to collect image information of the sealing area of the biological product based on the sealing area positioning coordinates.
[0017] Activate the high-precision camera and use the sealing area positioning coordinates to collect image information of the sealing area of the biological product. Image acquisition based on coordinate information ensures the accuracy and pertinence of image data, laying a solid foundation for subsequent analysis and processing.
[0018] The image information of the sealing area is processed by a defect identifier to extract the false defect area.
[0019] During the seal inspection of biological products, the image information of the sealing area collected by the camera will be sent to the defect identifier for in-depth processing, and then the areas that are significantly different from the normal areas, namely the false defect areas, will be extracted. The false defect areas do not mean that these areas are not defects, but require further verification and analysis to determine whether they fall into the category of defects.
[0020] Furthermore, the image information of the sealing area is processed by a defect identifier to extract the false defect area, including: Obtain a defect texture set; obtain a positive sample sealing surface image of the biological product, wherein the positive sample sealing surface image has a sealing area wrinkle texture label; configure a defect compilation quantity constraint; according to the defect compilation quantity constraint, randomly compile the defect texture set to the positive sample sealing surface image, repeat several times, and obtain a negative sample sealing surface image, wherein the negative sample sealing surface image has a defect texture label; configure the defect identifier based on the positive sample sealing surface image and the negative sample sealing surface image as input data, and using the defect texture label and the sealing area wrinkle texture label as convolutional network output supervision data.
[0021] A series of defect texture images are collected from big data, which represent various possible sealing area defects, such as damage, stains, abnormal wrinkles, etc. These defect texture images are organized into a defect texture set for subsequent compilation into positive sample images. A series of biological product sealing surface images are collected from big data as positive sample sealing surface images, and the sealing area wrinkle texture labels are annotated for these positive sample images so that normal textures and defect textures can be distinguished during training. Among them, the positive sample sealing surface image should have a clear sealing area, and the sealing surface has no defects or only normal wrinkle textures. According to actual needs, the defect compilation quantity constraint is configured, that is, the number of defect textures compiled into the positive sample image each time is set to control the complexity and diversity of negative samples; image processing technology is used to randomly compile the textures in the defect texture set into the positive sample sealing surface image, and each compilation follows the previously set defect compilation quantity constraint; repeat this compilation process several times to generate a sufficient number of negative sample sealing surface images, and annotate these negative sample images with defect texture labels so that they can be distinguished from positive sample images during training. A convolutional neural network (CNN) is constructed by using positive sample sealing surface images and negative sample sealing surface images as input data, and defect texture labels and sealing area wrinkle texture labels as output supervision data. After multiple iterative training, a defect identifier is obtained, which can accurately identify defect textures in the sealing area of biological products.
[0022] A texture consistency analysis is performed on the pseudo defect area to obtain a selected defect area.
[0023] After processing the image information of the sealing area and extracting the false defect area, the texture consistency analysis of the false defect area is performed to further screen out the real defect area. By comparing the texture features of different parts of the area, the consistency and difference between them are evaluated. If most of the texture features in the area are similar and conform to the texture pattern of the normal sealing surface, the area may be a false defect that was misjudged; conversely, if there are significant texture changes or abnormal features in the area, it is more likely to be a real defect area.
[0024] Furthermore, if Figure 2 As shown, texture consistency analysis is performed on the pseudo defect area to obtain a selected defect area, including: Performing a longitudinal texture consistency analysis on the pseudo defect area to obtain a longitudinal selected defect area; performing a transverse texture consistency analysis on the pseudo defect area to obtain a transverse selected defect area; and setting the union of the longitudinal selected defect area and the transverse selected defect area as the selected defect area.
[0025] Preferably, for each pseudo defect area, a texture consistency analysis is performed along its longitudinal direction (i.e., the direction perpendicular to the sealing boundary line) to obtain a longitudinal selected defect area; a texture consistency analysis is performed on the pseudo defect area in the transverse direction (i.e., the direction parallel to the sealing boundary line) using a method similar to the longitudinal texture consistency analysis to obtain a transverse selected defect area; and the union of the longitudinal selected defect area and the transverse selected defect area is set as the final selected defect area. Through the above process, the texture consistency of the pseudo defect area can be more comprehensively evaluated, and the real defect area can be identified more accurately.
[0026] Furthermore, the longitudinal texture consistency analysis is performed on the pseudo defect area to obtain the longitudinal selected defect area, including: The pseudo-defect region is placed into the positioning space to obtain the positioning coordinate information of the pseudo-defect region; based on the positioning coordinate information of the pseudo-defect region, the pseudo-defect region is traversed to extract the longitudinal distribution length feature set of the pseudo-defect; outlier analysis is performed according to the longitudinal distribution length feature set of the pseudo-defect to obtain the first outlier pseudo-defect; the first outlier pseudo-defect is deleted from the positioning coordinate information of the pseudo-defect region to obtain the updated positioning coordinate information of the pseudo-defect region; according to the updated positioning coordinate information of the pseudo-defect region, the adjacent pseudo-defect regions in the longitudinal direction are traversed to extract the pseudo-defect distribution spacing feature set, wherein the defect spacing is the longitudinal center distance of the defect; outlier analysis is performed according to the pseudo-defect distribution spacing feature set to obtain the second outlier pseudo-defect; the first outlier pseudo-defect and the second outlier pseudo-defect are added to the longitudinal selected defect region.
[0027] Specifically, each false defect area is mapped into the positioning space to obtain the positioning coordinate information of the false defect area; each false defect area is traversed to obtain the distribution length of the false defect area in the longitudinal direction (perpendicular to the sealing boundary line) to form a false defect longitudinal distribution length feature set; the longitudinal distribution length feature set is analyzed for outliers using statistical methods (such as box plots, Z-score, etc.) to identify those outliers that are significantly different from most data points, and the false defects corresponding to these points are regarded as the first outlier false defects; the first outlier false defect is deleted from the false defect area positioning coordinate information to obtain updated coordinate information; based on the updated false defect area positioning coordinate information, the adjacent false defect areas in the longitudinal direction are traversed to calculate the longitudinal center distance between adjacent defects as the defect spacing feature, and all defect spacing features are integrated to form a false defect distribution spacing feature set; the defect spacing feature set is analyzed for outliers to identify those outliers whose spacing is significantly different from other defects, and the false defects corresponding to these points are regarded as the second outlier false defects; the first outlier false defect and the second outlier false defect are added to the longitudinal selected defect area. Through the above steps, the characteristics of the false defect area can be analyzed more finely, and outliers can be effectively identified and excluded, so as to more accurately determine the longitudinal selected defect area.
[0028] Furthermore, performing outlier analysis according to the pseudo-defect distribution spacing feature set to obtain a second outlier pseudo-defect includes: An outlier analysis is performed based on the pseudo-defect distribution spacing feature set to obtain an outlier spacing feature set; when the first distribution spacing feature and the second distribution spacing feature of the pseudo-defect to be analyzed both belong to the outlier spacing feature set, the pseudo-defect to be analyzed is added to the second outlier pseudo-defect.
[0029] Preferably, the pseudo-defect distribution spacing feature set is analyzed for outliers using statistical methods (such as box plots, IQR, etc.) to identify points that are significantly different from most spacing features, and the spacing values corresponding to these points are regarded as outlier spacing features, and all outlier spacing features are integrated into a set, namely, the outlier spacing feature set; for each pseudo-defect to be analyzed, it is necessary to calculate the first distribution spacing feature and the second distribution spacing feature of the pseudo-defect, the first distribution spacing feature is the longitudinal center distance between the defect and its previous adjacent defect, and the second distribution spacing feature is the longitudinal center distance between the defect and its subsequent adjacent defect; the first distribution spacing feature and the second distribution spacing feature of the pseudo-defect to be analyzed are compared with the outlier spacing feature set, if both of these spacing features exist in the outlier spacing feature set, that is, they both significantly deviate from the normal spacing range, then it can be considered that the pseudo-defect to be analyzed is abnormal in spacing and is likely to be a real defect, therefore, the pseudo-defect to be analyzed is added to the second outlier pseudo-defect set.
[0030] When the size specification of the selected defect area meets the failure size specification, the biological product is marked as sealed failure.
[0031] After completing the detailed analysis and confirmation of the selected defect areas, it is possible to evaluate whether these defects have a real impact on the sealing performance of the biological product. Specifically, according to the characteristics and usage requirements of the biological product, a series of failure size specifications are set, which define which size and shape defects will cause sealing failure; according to the preset failure size specifications, the size specifications of the selected defect area are evaluated; if the size specifications of the selected defect area meet or exceed the preset failure size specifications, the biological product will be immediately marked as sealed.
[0032] Furthermore, when the size specification of the selected defect area meets the failure size specification, the biological product is marked as sealed failure, including: Extract a set of color feature values of the selected defect area, wherein the color feature value set has a set of color feature value distribution coordinates; fit the color feature value set through a defect color calibration network to obtain a defect color feature value set; distribute the defect color feature value set according to the color feature value distribution coordinate set to obtain a selected updated defect area; when the size specification of the selected updated defect area meets the failure size specification, mark the biological product as sealed and failed.
[0033] Preferably, color analysis is performed on the pixels in the selected defect area to extract color feature values, which may include RGB values and HSV values. These color feature values are combined into a set, and the distribution coordinates of each color feature value in the defect area are recorded at the same time to form a color feature value distribution coordinate set; a pre-trained defect color calibration network (such as a convolutional neural network CNN based on a deep learning model) is used to fit the extracted color feature value set, and the defect color calibration network can identify color feature patterns that are highly correlated with defects, and filter out a more accurate defect color feature value set from the original color feature value set; using color The color feature value distribution coordinate set is used to remap the screened defect color feature values back to the original image space to form a selected updated defect area, which more accurately reflects the location and shape of the actual defect; the size specifications of the selected updated defect area, including parameters such as length, width, and area, are measured, and these size specifications are compared with the preset failure size specifications; if any size specification of the selected updated defect area exceeds the threshold of the failure size specification, it is considered that the defect has a real impact on the sealing performance of the biological product; if the size specification of the selected updated defect area meets the failure size specification, the biological product is marked for sealing failure according to the previous method. Through the above process, color features can be used to further refine and update the selected defect area, thereby improving the accuracy and reliability of sealing detection.
[0034] Furthermore, fitting the color feature value set through the defect color calibration network to obtain the defect color feature value set includes: A set of color feature values of non-sealing failure defects and a set of color feature values of sealing failure defects are collected to construct a classifier input data set; and the defect color calibration network is configured according to the classifier input data set.
[0035] From the samples of biological products with non-sealing failure, select areas containing various non-sealing failure defects (such as scratches, stains, color difference, etc.), extract color feature values from these areas, and form a non-sealing failure defect color feature value set with these color feature values and their corresponding labels (non-sealing failure) as part of the classifier input data set; from the samples of biological products with sealing failure, select areas containing sealing failure defects (such as holes, cracks, bubbles, etc.), similarly, extract color feature values from these areas, and form a sealing failure defect color feature value set with these color feature values and their corresponding labels (sealing failure) as another part of the classifier input data set; merge the non-sealing failure defect color feature value set and the sealing failure defect color feature value set to form a complete classifier input data set; use the constructed classifier input data set to train the defect color calibration network, which is based on a convolutional neural network and can output a model of defect type (non-sealing failure or sealing failure) according to the color feature value input. Through the above steps, a defect color calibration network based on color feature values can be constructed to identify sealing failure defects in biological products.
[0036] In summary, the embodiments of the present application have at least the following technical effects: First, the biological product is sealed by a first flexible sealing material and a second flexible sealing material and transmitted to a first detection platform. The biological product has a sealing area positioning coordinate on the first detection platform, wherein the sealing area is the sealing boundary area of the first flexible sealing material and the second flexible sealing material. Next, the camera is activated to collect the sealing area image information of the biological product based on the sealing area positioning coordinate. Then, the sealing area image information is processed by a defect identifier to extract the false defect area. Finally, a texture consistency analysis is performed on the false defect area to obtain a selected defect area; when the size specification of the selected defect area meets the failure size specification, the biological product is marked as sealed. The technical problem of poor accuracy in the detection of sealing failure of biological products in the prior art is solved, and the technical effect of improving detection efficiency and accuracy is achieved through image recognition technology.
[0037] It should be noted that the above-mentioned sequence of the embodiments of the present application is only for description and does not represent the advantages and disadvantages of the embodiments. And the above-mentioned specific embodiments of this specification are described. The processes depicted in the accompanying drawings do not necessarily require the specific order or continuous order shown to achieve the desired results. In some embodiments, multitasking and parallel processing are also possible or may be advantageous.
[0038] The above description is only a preferred embodiment of the present application and is not intended to limit the present application. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present application shall be included in the protection scope of the present application.
[0039] This specification and drawings are merely exemplary illustrations of the present application and are deemed to cover any and all modifications, variations, combinations or equivalents within the scope of the present application. Obviously, a person skilled in the art may make various modifications and variations to the present application without departing from the scope of the present application. Thus, if these modifications and variations of the present application fall within the scope of the present application and its equivalents, the present application intends to include these modifications and variations.
Claims
1. Biological product sealing failure detection method based on image recognition, It is characterized in that The method comprises: The biological product is sealed by a first flexible sealing material and a second flexible sealing material and transmitted to a first detection platform, wherein the biological product has a sealing area positioning coordinate on the first detection platform, wherein the sealing area is a sealing interface area between the first flexible sealing material and the second flexible sealing material; activating a camera to collect image information of the sealing area of the biological product based on the sealing area positioning coordinates; Processing the image information of the sealing area by a defect identifier to extract a false defect area; Performing texture consistency analysis on the pseudo defect area to obtain a selected defect area; When the size specification of the selected defect area meets the failure size specification, the biological product is marked as sealed failure.
2. The method for detecting sealing failure of biological products based on image recognition according to claim 1, It is characterized in that The image information of the sealing area is processed by a defect identifier to extract the false defect area, including: Get defect texture set; Obtaining a positive sample sealing surface image of the biological product, wherein the positive sample sealing surface image has a sealing area wrinkle texture label; Configure defect compilation quantity constraints; According to the defect compilation quantity constraint, randomly compile the defect texture set to the positive sample sealed surface image, repeat several times, and obtain a negative sample sealed surface image, wherein the negative sample sealed surface image has a defect texture label; The defect identifier is configured based on the positive sample sealing surface image and the negative sample sealing surface image as input data, and the defect texture label and the sealing area wrinkle texture label as convolutional network output supervision data.
3. The method for detecting sealing failure of biological products based on image recognition according to claim 1, It is characterized in that Performing texture consistency analysis on the pseudo defect area to obtain a selected defect area includes: Performing longitudinal texture consistency analysis on the pseudo defect area to obtain a longitudinal selected defect area; Performing a transverse texture consistency analysis on the pseudo defect area to obtain a transverse selected defect area; The union of the longitudinal selected defect region and the transverse selected defect region is set as the selected defect region.
4. The method for detecting sealing failure of biological products based on image recognition as claimed in claim 3, It is characterized in that Performing longitudinal texture consistency analysis on the pseudo defect area to obtain a longitudinal selected defect area includes: The pseudo defect area is placed into the positioning space to obtain the positioning coordinate information of the pseudo defect area; Based on the positioning coordinate information of the pseudo defect area, traverse the pseudo defect area to extract a pseudo defect longitudinal distribution length feature set; Performing outlier analysis based on the pseudo-defect longitudinal distribution length feature set to obtain a first outlier pseudo-defect; Deleting the first outlier false defect from the false defect area positioning coordinate information to obtain false defect area positioning updated coordinate information; According to the positioning and updating coordinate information of the pseudo defect area, traversing the adjacent pseudo defect areas in the longitudinal direction, and extracting the pseudo defect distribution spacing feature set, wherein the defect spacing is the longitudinal center distance of the defect; Performing outlier analysis according to the pseudo-defect distribution spacing feature set to obtain a second outlier pseudo-defect; The first outlier false defect and the second outlier false defect are added into the longitudinal selected defect area.
5. The method for detecting sealing failure of biological products based on image recognition as claimed in claim 4, It is characterized in that Performing outlier analysis according to the pseudo-defect distribution spacing feature set to obtain a second outlier pseudo-defect includes: Performing outlier analysis based on the pseudo-defect distribution spacing feature set to obtain an outlier spacing feature set; When the first distribution spacing feature and the second distribution spacing feature of the pseudo defect to be analyzed both belong to the outlier spacing feature set, the pseudo defect to be analyzed is added into the second outlier pseudo defect.
6. The method for detecting sealing failure of biological products based on image recognition according to claim 1, It is characterized in that The biological product is sealed by a first flexible sealing material and a second flexible sealing material and transmitted to a first detection platform, wherein the biological product has a sealing area positioning coordinate on the first detection platform, comprising: Obtaining sealing control parameters of the first flexible sealing material and the second flexible sealing material for the biological product, wherein the sealing control parameters have coordinate feature identifiers; According to the sealing control parameters, performing regional clustering analysis on the coordinate feature identifiers to obtain regional clustering results, wherein the same category of the regional clustering results has the same sealing control parameters; The regional clustering results are added to the sealing area positioning coordinates.
7. The method for detecting sealing failure of biological products based on image recognition according to claim 1, It is characterized in that When the size specification of the selected defect area meets the failure size specification, the biological product is marked as sealed failure, including: Extracting a color feature value set of the selected defect area, wherein the color feature value set has a color feature value distribution coordinate set; Fitting the color feature value set through a defect color calibration network to obtain a defect color feature value set; Distributing the defect color feature value set according to the color feature value distribution coordinate set to obtain a selected updated defect area; When the size specification of the selected updated defect area meets the failure size specification, the biological product is marked as sealed failure.
8. The method for detecting sealing failure of biological products based on image recognition according to claim 7, It is characterized in that The color feature value set is fitted by a defect color calibration network to obtain a defect color feature value set, including: Collecting a set of color feature values of non-sealing failure defects and a set of color feature values of sealing failure defects to construct a classifier input data set; The defect color calibration network is configured according to the classifier input data set.
Citation Information
Patent Citations
Image multifeature extraction and fusion method and system
CN102663391A
Dark field image target point accurate extraction method based on integrated decision tree
CN114120318A
Raw material quality inspection method for donkey-hide gelatin product production
CN115457037A
Method for detecting appearance defects of laser welding seam
CN115797354A
Method and system for improving defect judgment efficiency
CN116559183A
